Top Markets
Coin of the day
Vaxart, Inc. Vaxart, Inc.

Vaxart, Inc.

VXRT
Classement en actions #20648
Vaxart, Inc. operates as a biotechnology firm currently in the clinical... Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company leverages its unique proprietary platform for delivering these oral vaccine solutions. Its diverse pipeline showcases several promising candidates: An oral tablet vaccine targeting norovirus, which is presently undergoing Phase Ib clinical assessment for both GI.1 and GII.4 strains. A seasonal influenza vaccine, now in Phase II clinical studies, designed to address H1 influenza infections. A vaccine candidate against respiratory syncytial virus (RSV). A coronavirus vaccine, also advancing through Phase II clinical trials for SARS-CoV-2. Beyond infectious diseases, Vaxart is also engaged in formulating therapeutic vaccines aimed at treating cervical cancer and dysplasia associated with human papillomavirus. The company's main operations are situated in South San Francisco, California.
Prix de l'action
$0.517
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$125.14M
Changement (1 jour)
-0.58%
Changement (1 an)
47.71%
Pays
US
Échange Vaxart, Inc. (VXRT)

Catégorie

Le prix VXRT avec la capitalisation boursière de B
Vaxart, Inc. Vaxart, Inc.
VXRT
$0.517
Capitalisation boursière de Vaxart, Inc.(VXRT)
Capitalisation boursière: $125.14M
En August 2026, Vaxart, Inc. a une capitalisation boursière de $125.14M. Cela fait de Vaxart, Inc. la 20648th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Vaxart, Inc. du 1981 au 2026
VXRT par rapport au top 5 des plus populaires stocks
Prix pour VXRT L’actif B La capitalisation boursière de B Résultats
Vaxart, Inc. Vaxart, Inc.
$21,530.68 $125.14M
$5.211T +4,164,442.00%
Vaxart, Inc. Vaxart, Inc.
$18,784.80 $125.14M
$4.547T +3,633,324.35%
Vaxart, Inc. Vaxart, Inc.
$17,197.20 $125.14M
$4.162T +3,326,244.06%
Vaxart, Inc. Vaxart, Inc.
$14,843.55 $125.14M
$3.593T +2,870,993.60%
Vaxart, Inc. Vaxart, Inc.
$11,538.63 $125.14M
$2.793T +2,231,743.37%